Case Based Peer Perspectives

Melissa Alsina, MD introduces the case of a patient with newly diagnosed multiple myeloma, discusses best practices for treating transplant-not-preferred patients, and engages with emergent trial data.

Expert oncologist Matthew Powell, MD, reviews the case of a woman with endometroid adenocarcinoma and considers optimal treatment strategies in this setting.

Natalie Callander, MD, presents the case of a patient with transplant-preferred newly diagnosed multiple myeloma and reviews treatment paradigms and clinical trial data.

Catherine C. Coombs, MD, presents a patient case and provides clinical insights on evolving treatment paradigms for patients with relapsed/refractory CLL.

Expert gynecologic oncologist Ritu Salani, MD, MBA, reviews a case of recurrent endometrial cancer to highlight treatment approaches and management strategies in this setting.

Expert oncologist Kevin Kalinsky, MD, centers discussion on a patient case of HR+/HER2-low metastatic breast cancer to highlight current treatment options and best practices.

Matthew R. Smith, MD, PhD presents a nonmetastatic castration-resistant prostate cancer (CRPC) patient case, discusses how clinical trial data informs his treatment selection, and shares clinical pearls for community oncologists treating patients with CRPC.

Rana McKay, MD presents a metastatic castration-resistant prostate cancer patient case, discusses standards of care in the prostate cancer treatment landscape, and shares emergent clinical trial data.

Nelson J. Chao, MD, an expert on graft-vs-host disease, discusses a profile of a patient with GVHD, and analyzes the evolving treatment landscape.

Abdulraheem Yacoub, MD, presents the case of a 68-year-old woman with myelofibrosis and details the evolving treatment landscape.

John Allan, MD, presents the case of a 72-year-old woman with chronic lymphocytic leukemia, and discusses the treatment landscape for patients with newly diagnosed CLL.

Monty Pal, MD, FASCO, presents a case of a 71-year-old patient with relapsed-refractory mRCC and discusses his data-informed rationale for treatment selection and sequencing in the treatment landscape of metastatic renal cell carcinoma.

Centering discussion on a patient case of metastatic breast cancer, expert oncologist Hope Rugo, MD, FASCO, highlights systemic therapy selection and best practices in this setting.

Prithviraj Bose, MD presents a polycythemia vera (PV) patient case, reviews the biology of PV, and shares how existing and emergent trial data inform treatment selection and patient monitoring for his patients.

Yi-Bin Chen, MD, presents the case of a 48-year-old man with graft-vs-host disease, and discusses the overall treatment landscape for GVHD.

Chandler Park, MD presents a renal cell carcinoma (RCC) patient case, discusses current standards of care in the RCC treatment landscape, and analyses emergent data from RCC clinical trials.

Hussein Tawbi, MD, PhD shares a patient case study of BRAF-mutant metastatic melanoma before discussing standards of care for such patients in the first-line systemic therapy setting, effective treatment sequencing and adverse event management strategies, and current unmet needs in the field.

Expert oncologist Marina Chiara Garassino, MD, reviews the case of a 72-year-old woman with advanced stage NSCLC and considers optimal treatment pathways.

Peter Voorhees, MD, presents the case of a 63-year-old man with R/R multiple myeloma and discusses the potential role of non-BCMA-targeting bispecifics in the treatment landscape for multiple myeloma.

Esteemed medical oncologist Matthew Galsky, MD, discusses the case of a 55-year-old man with muscle-invasive bladder cancer (MIBC) and reviews the options for treatment in the adjuvant setting.

Robert Holloway, MD, presents a patient case of metastatic endometrial cancer and discusses the systemic therapy options and recommended guidelines in this setting.

Shaji Kumar, MD, presents the case of a 63-year-old woman with R/R multiple myeloma and discusses how recent data updates of bispecifics influence treatment decision-making for patients.

Expert oncologist Terence Friedlander, MD, discusses the case of a 75-year-old woman with muscle-invasive bladder cancer and reviews the options for treatment in the adjuvant setting.

Expert oncologist Jason Porter, MD, centers discussion on a patient case of non–small cell lung cancer and highlights novel treatment modalities in this setting.

Eric Jonasch, MD, presents the case of a 72-year-old male with advanced renal cell carcinoma (RCC) and discusses how recent data updates influence treatment decision-making.

Centering his discussion on a patient case of metastatic melanoma, expert oncologist Sajeve Thomas, MD, reflects on the current treatment paradigm and highlights best practices in care.

Rana McKay, MD, presents the case of a 73-year-old man with advanced renal cell carcinoma (RCC) and reviews how recent data updates influence treatment decision-making.

Sheela Tejwani, MD, reviews the case of an 83-year-old man with biochemically recurrent mCSPC and discusses the possible treatment approaches.

Expert oncologist, Daniel George, MD, reviews the case of 68-year-old woman who is diagnosed and treated for advanced renal cell carcinoma.

Centering discussion on a patient case of endometrial cancer, expert oncologist Bhavana Pothuri, MD, highlights systemic therapy and best practices in this setting.